Inhibrx
INBX
$34.30
Share price
0.44%
Change (1 day)
29.68%
Change (1 year)
Categories
Earnings for Inhibrx (INBX)
Earnings in 2023 (TTM): -$0.24 B
According to Inhibrx's latest financial reports the company's current earnings (TTM) are -$0.24 B. In 2022 the company made an earning of -$0.15 B a decrease over its 2021 earnings that were of -$81.77 M.The earnings displayed on this page is the company's Pretax Income.
Earnings history for Inhibrx from 2019 to 2023
Annual earnings
| Year | Earnings | Change |
|---|---|---|
2023 (TTM)  | -$0.24 B | 65.07% |
| 2022 | -$0.15 B | 77.61% |
| 2021 | -$81.77 M | 8.11% |
| 2020 | -$75.64 M | 49.76% |
| 2019 | -$50.51 M |
Earnings for similar companies or competitors
| Company | Earnings | Earnings differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | -$0.12 B | -53.79% | 🇺🇸 USA |